MedNet is representing Arkema in all countries in Europe, Middle East and Africa. Foster Corporation, already Arkema’s primary polymers distributor in North America and Asia, will also continue to be represented in Europe by MedNet. MedNet will make use of its distribution channels and market position in Europe giving customers the benefit of a single, local point of contact for Foster’s extensive compound portfolio and Arkema’s specialty resins.
“Building on our steady and successful collaboration with Foster Corporation for many years, we look forward to deepening relationships and expanding sales activities for medical resins by partnering with Arkema. Based on our critical market knowledge and experience, as well as our long-standing customer relations, we can perfectly support the success of all parties involved and provide the best possible service to our customers,” MedNet Managing Director Matthias Heinz said.
Foster and Arkema have had a long and successful relationship with regard to the marketing and distribution of Arkema’s “MED” grade products into critical medical applications in North America and Asia. Now, the reach of this partnership will extend with the addition of MedNet.
“We are extremely pleased to establish this relationship with MedNet and Foster. This distribution partnership reach and expertise in the medical market will help Arkema to successfully grow our business in EMEA, including our 100% bio-circular Rilsan MED polyamide 11 and our flagship Pebax MED elastomers,” said Francois Ruas, Health & Beauty global market manager at Arkema.
“MedNet’s experience in the EMEA healthcare market is unmatched and they will be able to leverage that experience, with Foster’s expertise to further develop new business opportunities for Arkema healthcare products in this region," said Larry Johnson, president of Foster Distribution. "In addition, we can assure customers for Arkema’s “MED” products in the EMEA that the Foster/MedNet partnership will work together diligently to ensure an efficient transition and provide unbeaten customer service.”
Since 1990 MedNet GmbH has been a service provider and supplier for the medical device and pharmaceutical industry. As a European company with headquarters in Germany it offers a wide portfolio in standard components from well-known manufacturers as well as own product lines for interventional radiology, infusion technology and others. MedNet also provides a worldwide well established network for medical materials and manufacturing providers offering distribution and marketing channels to the European market. With this extensive portfolio MedNet can provide various and customized solutions for medical device manufacturers from one hand. MedNet is ISO 13485 certified.
Building on its expertise in materials science, Arkema offers technologies to address ever-growing demand for new and sustainable materials. With the ambition to become in 2024 a pure player in specialty materials, the Group is structured into three complementary, resilient and innovative segments dedicated to specialty materials—Adhesive Solutions, Advanced Materials, and Coating Solutions—accounting for some 85.5% of Group sales in 2021, and a well-positioned and competitive Intermediates segment. Arkema offers technological solutions to meet the challenges of, among other things, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group reported sales of approximately €9.5 billion in 2021, and operates in about 55 countries with 20,200 employees worldwide.
For more than 30 years, Foster Corporation has been serving medical device manufacturers with technology and service in biomedical materials. These include custom medical compounds, implantable materials, and polymer distribution. Within ISO 13485:2016 facilities, Foster offers comprehensive support to customers from formulation development through production.
Together with Foster Corporation, MedNet becomes the distributor of High Perfor-mance Polymers for Medical Applications in Europe and will supply Arkema’s Pebax® MED, Rilsan® MED, Rilsamid® MED, Rilsan® Clear MED and Kynar® MED product ranges.